Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Azar Rezapour

2PUBLICATIONS

8CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|May 14, 2023

A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8<sup>+</sup> T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma.

Azar Rezapour, Daniel Rydbeck, Fabian Byvald

|Oct 23, 2021

Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T Cells.

Frank Liang, Azar Rezapour, Louis Szeponik

Pageof 1

Frequent Collaborators

2 joint publications

Ulf Yrlid

1 joint publications

Frank Liang

1 joint publications

Louis Szeponik

1 joint publications

Samuel Alsén

1 joint publications

Marianne Quiding-Järbrink

1 joint publications

Fabian Byvald

1 joint publications

Viktor Tasselius

1 joint publications

Eva Angenete

Frequent Collaborators

2 joint publications

Ulf Yrlid

1 joint publications

Frank Liang

1 joint publications

Louis Szeponik

1 joint publications

Samuel Alsén

Top Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells

Published on : Feb 08, 2018

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

See more related videos

Top Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells

Published on : Feb 08, 2018

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

See more related videos